tiprankstipranks
Advertisement
Advertisement

Avalon GloboCare, AWS Advance Agentic AI Video Platform

Story Highlights
  • Avalon Quantum AI partnered with AWS and Caylent to accelerate Phase 2 of its Catch-Up agentic AI video platform.
  • The project, backed by $125,000 in AWS funding, aims to create an autonomous AI video system for non-technical content creators and expand Avalon’s SaaS reach.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Avalon GloboCare, AWS Advance Agentic AI Video Platform

Claim 55% Off TipRanks

Avalon GloboCare ( (ALBT) ) has provided an update.

On April 21, 2026, Avalon GloboCare announced that its subsidiary Avalon Quantum AI is collaborating with Amazon Web Services to support Phase 2 development of its Catch-Up agentic AI video platform. AWS has agreed to provide $125,000 of funding contingent on project completion within seven months, with the work currently projected to finish in about four months.

Caylent, an AWS Premier Tier Consulting Partner and member of the AWS Generative AI Innovation Center’s Partner Innovation Alliance, has been appointed to lead this development, which aims to convert Catch-Up from a manually configured tool into a fully autonomous agentic AI video system. The upgrade is intended to let non-technical content creators generate personalized video for multiple social platforms, which Avalon’s management describes as a validation of its technology roadmap and a step toward scaling its software-as-a-service model and broadening market adoption.

More about Avalon GloboCare

Avalon GloboCare Corp., listed on Nasdaq as ALBT, is a technology-innovation company focused on products and services for growing consumer health and technology markets. Through its wholly owned subsidiary Avalon Quantum AI LLC, it is developing next-generation agentic AI systems for automated video generation, small business marketing, and workflow automation, and it also distributes the FDA-registered KetoAir ketosis breathalyzer in North America.

The company’s portfolio reflects a strategy of combining consumer health devices with AI-driven software solutions to tap demand from content creators and small enterprises. This dual focus positions Avalon at the intersection of digital health and generative AI, aiming to build recurring software revenues while leveraging regulated medical-device distribution channels.

Average Trading Volume: 7,210,147

Technical Sentiment Signal: Sell

Current Market Cap: $3.18M

For an in-depth examination of ALBT stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1